Dietary and nutritional needs of patients after therapy for head and neck cancer

Journal of the American Dental Association

Volumn 143, Issue 6, 2012, Pages 588-592

  Epstein, Joel B ^a   Huhmann, Maureen B ^b  

^a Division of Otolaryngology   (United States)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Cancer survivors; Cancer therapy; Diet and nutrition; Head and neck cancer; Oral complications

Indexed keywords

EID: 84862738569     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2012.0237     Document Type: Article

References (38)

1. Centers for Disease Control and Prevention. Cancer survivors: United States, 2007. MMWR Morb Mortal Wkly Rep 2011;6(K9):270.
2. Cooperstein E, Gilbert J, Epstein JB, et al. Vanderbilt Head and Neck Symptom Survey Version 2.0: report of the development and initial testing of a subscale for assessment of oral health (published online ahead of print Aug. 24, 2011). Head Neck doi:10.1002/ hed.21816.
3. Brown CG, McGuire DB, Peterson DE, Beck SL, Dudley WN, Mooney KH. The experience of a sore mouth and associated symptoms in patients with cancer receiving outpatient chemotherapy. Cancer Nurs 2009;32(4):259-270.
4. Murphy BA, Gilbert J. Dysphagia in head and neck cancer patients treated with radiation: assessment, sequelae, and rehabilitation. Semin Radiat Oncol 2009;19(1):35-42.
5. Gaziano JE. Evaluation and management of oropharyngeal dysphagia in head and neck cancer. Cancer Control 2002;9(5):400-409. (Pubitemid 35204462)
6. National Dysphagia Diet Task Force, American Dietetic Association. National Dysphagia Diet: Standardization for Optimal Care. Chicago: American Dietetic Association; 2002.
7. Jensen SB, Pederson AM, Vissink A, et al; Salivary Gland Hypofunction/ Xerostomia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCCyinternational Society of Oral Oncology (ISOO). A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life (published online ahead of print March 17, 2010). Support Care Cancer 2010;18(8): 1039-1060. doi:10.1007/s00520-010-0827-8.
8. Cooper JS, Fu K, Marks J, Silverman S. Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys 1995;31(5):1141-1164.
9. Logemann JA, Pauloski BR, Rademaker AW, et al. Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck 2003;25(6):432-437. (Pubitemid 36577026)
10. Rodrigues NA, Killion L, Hickey G, et al. A prospective study of salivary gland function in lymphoma patients receiving head and neck irradiation (published online ahead of print March 26, 2009). Int J Radiat Oncol Biol Phys 2009;75(4):1079-1083. doi:10.10167 j.rjrobp.2008.12.053.
11. Van Rij CM, Oughlane-Heemsbergen WD, Ackerstaff AH, Lamers EA, Balm AJ, Rasch CR. Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life. Radiat Oncol 2008;3:41.
12. Mossman K, Shatzman A, Chencharick J. Long-term effects of radiotherapy on taste and salivary function in man. Int J Radiat Oncol Biol Phys 1982;8(6):991-997. (Pubitemid 12038677)
13. Oates JE, Clark JR, Read J, et al. Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2007;133(6): 533-540. (Pubitemid 46974881)
14. Garg AK, Malo M. Manifestations and treatment of xerostom and associated oral effects secondary to head and neck radiation therapy. JADA 1997;128(8):1128-1133. (Pubitemid 127457033)
15. Garcia MK, Chiang JS, Cohen L, et al. Acupuncture for radiation-induced xerostomia in patients with cancer: a pilot study. Head Neck 2009;31(10):1360-1368.
16. Schiff E, Mogilner JG, Sella E, et al. Hypnosis for postradiation xerostomia in head and neck cancer patients: a pilot study (published online ahead of print Jan. 31, 2009). J Pain Symptom Manage 2009;37(6):1086-1092.el. doi:10.1016/j.jpainsymman.2008.07.005.
17. Pacholke HD, Amdur RJ, Morris CG, et al. Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol 2005;28(4):351-358. (Pubitemid 41099539)
18. Epstein JB, Hong C, Logan RM, et al. A systematic review of orofacial pain in patients receiving cancer therapy (published online ahead of print June 11, 2010). Support Care Cancer 2010;18(8): 1023-1031. doi:10.1007/s00520-010- 0897-7.
19. Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Bisphosphonate- associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 2005;104(1):83-93. (Pubitemid 40847755)
20. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61(9):1115-1117. (Pubitemid 37064711)
21. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB. Managing the care of patients with bisphosphonateassociated osteonecrosis: an American Academy of Oral Medicine position paper (published correction appears in JADA 2006;137[1]:26)
22. JADA 2005;136(12):1658-1668
23. Scott B, Butterworth C, Lowe D, Rogers SN. Factors associated with restricted mouth opening and its relationship to health-related quality of life in patients attending a maxillofacial oncology clinic (published online ahead of print Sept. 7, 2007). Oral Oncol 2008; 44(5):430-438.doi:10.1016/j. oraloncology.2007.06.015. (Pubitemid 351622005)
24. Rothwell BR. Prevention and treatment of the orofacial complications of radiotherapy. JADA 1987;114(3):316-322. 8. Nelson GM. Biology of taste buds and the clinical problem of taste loss. Anat Rec 1998;253(3):70-78.
25. Nelson GM. Biology of taste buds and the clinical problem of taste loss. Anat Rec 1998;253(3):70-78 (Pubitemid 28387744)
26. Epstein JB, Barasch A. Taste disorders in cancer patients: pathogenesis, and approach to assessment and management (published online ahead of print Dec. 28, 2009). Oral Oncol 2010;46(2): 77-81. doi:10.1016/j.oraloncology.2009.11.008.
27. Yamashita H, Nakagawa K, Hosoi Y, et al. Umami taste dysfunction in patients receiving radiotherapy for head and neck cancer (published online ahead of print July 11,2008). Oral Oncol 2009;45(3): el9-e23. doi:10.1016/j. oraloncology.2008.04.001.
28. Sandow PL, Hejrat-Yazdi M, Heft MW. Taste loss and recovery following radiation therapy. J Dent Res 2006;85(7):6Q8-611. (Pubitemid 44085949)
29. Chasen MR, Bhargava R. A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer (published online ahead of print July 18, 2009). Support Care Cancer 2009;17(11):1345-1351. doi:10.1007/s00520-009-0684-5.
30. Schubert MM, Correa ME. Oral graft-versus-host disease. Dent Clin North Am 2008;52(1):79-109, viii-ix.
31. Peregrin T. Improving taste sensation in patients who have undergone chemotherapy or radiation therapy. J Am Diet Assoc 2006;106(10):1536-1540. (Pubitemid 44415603)
32. Dykstra PU, Kalk WW, Roodenburg JL. Trismus in head and neck oncology: a systematic review. Oral Oncol 2004;40(9):879-889. (Pubitemid 39369559)
33. Louise Kent M, Brennan MT, Noll JL, et al. Radiation-induced trismus in head and neck cancer patients (published online ahead of print Oct. 27, 2007). Support Care Cancer 2008;16(3):305-309. doi: 10.1007/800520-007-0345-5. (Pubitemid 351422806)
34. Bhatia KS, King AD, Paunipagar BK, et al. MRI findings in patients with severe trismus following radiotherapy for nasopharyngeal carcinoma (published online ahead of print June 6, 2009). Eur Radiol 2009;19(11):2586-2593. doi:10.1007/s00330-009-1445-z.
35. Leonard M. Trismus: what is it, what causes it, and how to treat it. Dent Today 1999;18(6):74-77.
36. Heller F, Wei FC, Chang YM, et al. A non-tooth-borne mouthopening device for postoperative rehabilitation after surgical release of trismus. Plast Reconstr Surg 2005;116(7):1856-1859.
37. Lalla RV, Latortue MC, Hong CH,et al; Fungal Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCO/International Society of Oral Oncology (ISOO). A systematic reviewof oral fungal infections in patients receiving cancer therapy (published online ahead of print May 8, 2010). Support Care Cancer 2010;18(8):985-992. doi:10.1007/s00520-010-0892-z.
38. Elad S, Zadik Y, Hewson I, et al;Viral Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCO/International Society of Oral Oncology ISOO). A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea (published online ahead of print June 11, 2010). Support Care Cancer 2010; 18(8):993-1006.doi:10.1007/s00520-010-0900-3.